» Articles » PMID: 363149

Release of a Special Fraction of the Outer Membrane from Both Growing and Phage T4-infected Escherichia Coli B

Overview
Specialties Biochemistry
Biophysics
Date 1978 Dec 4
PMID 363149
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Growing Escherichia coli release envelope material into the medium. Upon infection with T4 phage increased amounts of this material are released and at a greater rate. In order to determine whether both inner and outer membranes are present in this material, and whether the material released by growing cells differs from that released by infected cells, we have examined the protein composition of envelope released by growing and T4-infected E. coli B. Our results show: (a) the protein composition of envelope released from growing or infected cells is similar, (b) the proteins present are representative of the outer membrane, (c) the major outer membrane protein of E. coli B, protein II, is deficient in the released material. We therefore conclude that the envelope material released from growing or infected E. coli represents a special fraction of the outer membrane. This finding is discussed in relation to outer membrane structure and function. In addition, data are presented on the differing outer membrane protein composition of substrains of E. coli B obtained from different laboratories.

Citing Articles

Bacterial membrane vesicles: formation, functions, and roles in bacterial-phage interactions.

Xuan S, Xuan G World J Microbiol Biotechnol. 2024; 40(10):329.

PMID: 39304539 DOI: 10.1007/s11274-024-04148-y.


Proteomic analysis of carbapenem-resistant Klebsiella pneumoniae outer membrane vesicles under the action of phages combined with tigecycline.

Mao J, Yang X, Yan C, Wang F, Zheng R Ann Clin Microbiol Antimicrob. 2024; 23(1):73.

PMID: 39164718 PMC: 11337635. DOI: 10.1186/s12941-024-00734-y.


Transcending membrane barriers: advances in membrane engineering to enhance the production capacity of microbial cell factories.

Wu T, Jiang J, Zhang H, Liu J, Ruan H Microb Cell Fact. 2024; 23(1):154.

PMID: 38796463 PMC: 11128114. DOI: 10.1186/s12934-024-02436-8.


Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer.

Gao J, Su Y, Wang Z Adv Drug Deliv Rev. 2022; 186:114340.

PMID: 35569561 PMC: 9899072. DOI: 10.1016/j.addr.2022.114340.


Gut Microbiota Extracellular Vesicles as Signaling Molecules Mediating Host-Microbiota Communications.

Sultan S, Mottawea W, Yeo J, Hammami R Int J Mol Sci. 2021; 22(23).

PMID: 34884969 PMC: 8658398. DOI: 10.3390/ijms222313166.